Novo Nordisk A/S Class B

Novo Nordisk A/S Class B

285.20
DKK
+15.05
(+5.57%)
26.20EPS
11.99P/E
1.39TMarket Cap
Feb 03Next Earn

Novo Nordisk A/S Class B Documents

Q4 FY2025 · Interim report

Novo Nordisk - Q4 2025 - Interim Report · February 4, 2026 · 43 pages

Read Novo Nordisk A/S Class B's results firsthand

Preview the first 2 pages of this interim report
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents